BioSpace News Archive

Business

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Longboard Pharmaceuticals, Inc. today provided a corporate update and reported financial results for the second quarter ended June 30, 2021.

August 9, 2021
·
10 min read
Business

DarioHealth to Report Second Quarter 2021 Results on Monday, August 16

DarioHealth Corp. today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday, August 16, 2021 , and host a conference call and webcast at 8:30 am Eastern Time.

August 9, 2021
·
2 min read
Business

AcelRx to Host Second Quarter 2021 Financial Results Call and Webcast on August 16, 2021

AcelRx Pharmaceuticals, Inc. today announced that it will release second quarter financial results after market close on Monday, August 16, 2021 . AcelRx management will host a live webcast and conference call at 4:30 p.m. Eastern Time

August 9, 2021
·
2 min read
Deals

Thermo Fisher Scientific Announces Offering of USD-Denominated Senior Notes

Thermo Fisher Scientific Inc. (NYSE: TMO) (" Thermo Fisher ") announced today that it intends to offer USD-denominated senior notes.

August 9, 2021
·
2 min read
Business

ImmixBio Announces Dr. George W. Sledge of Stanford University Medical Center Joins Scientific Advisory Board

Immix Biopharma, Inc. today announced that George W. Sledge, MD, Professor of Medical Oncology and former Chief of Medical Oncology at Stanford University Medical Center has joined its Scientific Advisory Board.

August 9, 2021
·
2 min read
Pharm Country

Oramed to Present at Canaccord Genuity’s 41st Annual Growth Conference

Oramed Pharmaceuticals Inc. announced today that Chief Commercial Officer Michael Rabinowitz will present a company overview at Canaccord Genuity’s 41st Annual Growth Conference, held virtually this year from August 10-12, 2021.

August 9, 2021
·
3 min read
BioMidwest

SKYRIZI® (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis

AbbVie (NYSE: ABBV) today announced that SKYRIZI® (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, is now available in the U.S. as a single-dose 150 mg injection for the treatment of adults with moderate to severe plaque psoriasis.

August 9, 2021
·
7 min read
Business

ValGenesis Inc., Announces New VP of Marketing to Join its Executive Team

ValGenesis, Inc. today announced the appointment of Kevin Potts as Vice President of Marketing, effective August 1, 2021 .

August 9, 2021
·
2 min read
Deals

Nihon Kohden to Elevate Advancements Towards Improved Patient Outcomes with the Acquisition of Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.

Nihon Kohden has acquired Advanced Medical Predictive Devices, Diagnostics and Displays, Inc. (“AMP3D”), owners of a vast library of clinical predictive algorithms and a unique software-as-a-service (SaaS) platform.

August 9, 2021
·
4 min read
Genetown

Vicarious Surgical to Present at the Canaccord Genuity 41st Annual Growth Conference

Vicarious Surgical to Present at the Canaccord Genuity 41 st Annual Growth Conference

August 9, 2021
·
2 min read